Nicole P. Meyer-Morse, Ph.D.

Affiliations: 
2009 University of California, Berkeley, Berkeley, CA 
Area:
Molecular and cellular basis of microbial pathogenesis
Google:
"Nicole Meyer-Morse"

Parents

Sign in to add mentor
Daniel Portnoy grad student 2009 UC Berkeley
 (The cellular and immunological consequences of LLO mediated vacuolar escape.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Meyer-Morse N, Robbins JR, Rae CS, et al. (2010) Listeriolysin O is necessary and sufficient to induce autophagy during Listeria monocytogenes infection. Plos One. 5: e8610
Bahjat KS, Meyer-Morse N, Lemmens EE, et al. (2009) Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria. Plos Pathogens. 5: e1000568
Crimmins GT, Schelle MW, Herskovits AA, et al. (2009) Listeria monocytogenes 6-Phosphogluconolactonase mutants induce increased activation of a host cytosolic surveillance pathway. Infection and Immunity. 77: 3014-22
Leber JH, Crimmins GT, Raghavan S, et al. (2008) Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. Plos Pathogens. 4: e6
Viala JP, Mochegova SN, Meyer-Morse N, et al. (2008) A bacterial pore-forming toxin forms aggregates in cells that resemble those associated with neurodegenerative diseases. Cellular Microbiology. 10: 985-93
Joyce JA, Freeman C, Meyer-Morse N, et al. (2005) A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene. 24: 4037-51
Auerbuch V, Brockstedt DG, Meyer-Morse N, et al. (2004) Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. The Journal of Experimental Medicine. 200: 527-33
Joyce JA, Baruch A, Chehade K, et al. (2004) Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 5: 443-53
Bergers G, Song S, Meyer-Morse N, et al. (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. The Journal of Clinical Investigation. 111: 1287-95
Daniel D, Meyer-Morse N, Bergsland EK, et al. (2003) Immune enhancement of skin carcinogenesis by CD4+ T cells. The Journal of Experimental Medicine. 197: 1017-28
See more...